Search

47 search results for chris jones

Search results

'Olive oil' drug shows early promise for some brain cancer patients

Image: Glioblastoma cells under a microscope. Credit: Professor Chris Jones, The Institute of Cancer Research, London. A unique drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with an advanced form of the most common type of brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Results from the multi-centre Phase 1/2 study, which have

Cancer cells set to be launched into space for microgravity experiment on the International Space Station

Chris Jones, leader of the D(MG)2 study and Professor of Childhood Cancer Biology at The Institute

ICR celebrates a new generation of cancer researchers

Animal Welfare and Ethical Review Body, Board of Trustees member Professor Nicholas Jones, and ICR committee members Mr Chris Molloy and Mr Michael Sales were also named Members of the Institute

Researchers discover drug target for incurable childhood brain cancer

patients affected. Study author Dr Chris Jones, leader of the glioma team at The Institute

Babies with brain tumours could benefit from targeted treatment

in infants to be classed separately from other childhood brain tumours. Professor Chris Jones

Scientists Find Genes That Make Brain Tumours Treatment Resistant

lead to drug resistance for glioblastoma patients. Lead author Dr Chris Jones from the ICR says

Research projects

Research projects - The Institute of Cancer Research, London Research projects Professor Chris Lord, Gene Function group Synthetic lethal approaches to cancer treatment Our main research programmes, funded by Breast Cancer Now and Cancer Research UK, focus on understanding how to exploit, sarcomas expressing SS18-SSX fusion genes are also profoundly sensitive to ATR inhibition (Jones et al